American International Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,276
| Closed | -$191K | – | 1548 |
|
|
2024
Q1 | $191K | Sell |
4,276
-37
| -0.9% | -$1.65K | ﹤0.01% | 2171 |
|
|
2023
Q4 | $167K | Sell |
4,313
-17
| -0.4% | -$660 | ﹤0.01% | 2259 |
|
|
2023
Q3 | $127K | Buy |
4,330
+154
| +4% | +$4.53K | ﹤0.01% | 2371 |
|
|
2023
Q2 | $266K | Buy |
4,176
+1
| +0% | +$64 | ﹤0.01% | 2015 |
|
|
2023
Q1 | $197K | Buy |
4,175
+83
| +2% | +$3.92K | ﹤0.01% | 2115 |
|
|
2022
Q4 | $284K | Sell |
4,092
-15
| -0.4% | -$1.04K | ﹤0.01% | 1930 |
|
|
2022
Q3 | $602K | Buy |
4,107
+58
| +1% | +$8.5K | ﹤0.01% | 1464 |
|
|
2022
Q2 | $528K | Buy |
4,049
+367
| +10% | +$47.9K | ﹤0.01% | 1566 |
|
|
2022
Q1 | $372K | Buy |
3,682
+3,054
| +486% | +$309K | ﹤0.01% | 1891 |
|
|
2021
Q4 | $97K | Sell |
628
-19
| -3% | -$2.94K | ﹤0.01% | 2730 |
|
|
2021
Q3 | $191K | Buy |
+647
| New | +$191K | ﹤0.01% | 2455 |
|